Codexis, Inc.

    Jurisdiction
    United States
    LEI
    549300KGLM6CDPTVSE20
    ISIN
    US1920051067 (CDXS)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    51 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Codexis, Inc. discovers, develops, and sells enzymes and other proteins. Read full profile

    Fundamentals

    Net revenue
    €48.76M
    Gross margin
    77.6%
    EBIT
    -€48.83M
    EBIT margin
    -100.1%
    Net income
    -€55.42M
    Net margin
    -113.7%

    Statement period: - (published )

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Opaleye Management Inc. N/A +85K $2.68 +$227.80K
    Opaleye Management Inc. N/A +10K $2.82 +$28.20K
    Opaleye Management Inc. N/A +100K $2.82 +$282.00K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    James Anderson 1.7M $4.57M +5.6K Buy
    Peter Brown 651K $1.75M +287K Buy

    Earnings Calls

    Latest earnings call: August 13, 2025 (Q2 2025)

    Add to watchlist

    Notifications